A study examining the frequency of HER2 overexpression in GC/GEC in the Malaysian population would therefore provide valuable data unique to Malaysian patients and allow for cost-effective management of the cancer from the standpoint of early diagnosis and optimal therapeutic strategies. Here, ERBB2 is linked to cancer.